Cite
HARVARD Citation
Hobart, M. et al. (2018). Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study. Current medical research and opinion. pp. 633-642. [Online].